Literature DB >> 25393428

Defective nitric oxide metabolism in sickle cell disease.

Gregory J Kato1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25393428     DOI： 10.1002/pbc.25297

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  4 in total

Review 1.  Sickle Cell Disease: Advances in Treatment.

Authors:  Renée V Gardner
Journal:  Ochsner J       Date:  2018

2.  cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development.

Authors:  Andreas Friebe; Peter Sandner; Achim Schmidtko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-18       Impact factor: 3.000

3.  Azithromycin Reduces Markers of Vascular Damage in Pediatric Patients With Sickle Cell Disease.

Authors:  Peter N Uchakin; Vishwas S Sakhalkar; Francis C Dane; Olga N Uchakina; Jatayah N Sheed; William T Uphouse; Om V Sakhalkar
Journal:  J Hematol       Date:  2021-07-28

4.  Ocular manifestations of sickle cell disease and genetic susceptibility for refractive errors.

Authors:  Palak Shukla; Henu Verma; Santosh Patel; P K Patra; L V K S Bhaskar
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.